$IGC

IGC Pharma, Inc.

NYSE · Healthcare · Pharmaceutical Preparations · Potomac, MD

IGC chart

What traders are saying about $IGC

Latest posts

IGC Pharma, Inc. news

IGC Pharma, Inc. key financials

USD2025202420232022
Revenue–$1.3M$1.3M$911,000
Net income–-$7.1M-$13.0M-$11.5M
Diluted EPS–$-0.09$-0.22–
Total assets (year end)$9.7M$9.1M$11.3M$20.1M
Cash and equivalents (year end)$900,000$470,000$1.4M$4.9M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About IGC Pharma, Inc.

Ticker
IGC (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Potomac, MD
Incorporated in
MD
Fiscal year end
December 31
SEC CIK
1326205
Former names
India Globalization Capital, Inc.

Frequently asked questions

What exchange is IGC Pharma, Inc. listed on?

IGC Pharma, Inc. trades on the NYSE under the ticker symbol IGC.

What industry is IGC Pharma, Inc. in?

IGC Pharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is IGC Pharma, Inc. headquartered?

IGC Pharma, Inc.'s business address on file with the SEC is in Potomac, MD.

When does IGC Pharma, Inc.'s fiscal year end?

IGC Pharma, Inc.'s fiscal year ends on December 31.

How much revenue did IGC Pharma, Inc. report?

IGC Pharma, Inc. reported $1.3M in revenue for calendar year 2024, according to its SEC filings.